Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02017418 · ClinicalTrials.gov registry record · NA

The Effects of a Zeaxanthin Intervention on Visuomotor Function

A NA study of Behavior and Behavior Mechanisms, sponsored by University of Georgia.

Completed
Registry status
NA
Development phase
102
Enrollment target
1
Study location

NCT02017418 is a NA study of Behavior and Behavior Mechanisms that has completed, run by University of Georgia. The registered enrollment target is 102 participants, below the 170-participant average among 10 other Behavior and Behavior Mechanisms trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02017418, a NA study of Behavior and Behavior Mechanisms, has completed, sponsored by University of Georgia.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target
1
Study location

Study Summary

This study was designed to test whether two zeaxanthin formulations (supplements containing different nutritional compounds with zeaxanthin and omega fatty acids being the primary ingredients of interest) influenced visual motor function. Visual motor function refers to the processing speed of the visual system and how individuals respond behavioral to visual stimuli (e.g., reaction time).

Interventions

  • DIETARY_SUPPLEMENT zeaxanthin
  • DIETARY_SUPPLEMENT combinatory supplement

Study Locations (1)

Georgia

  • Department of Psychology, UGA - Athens

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2012-02
Est. Completion 2014-07
Phase NA

Sponsor

University of Georgia

59 total trials

What the Registry Record Tells You About NCT02017418

The ClinicalTrials.gov registry entry for NCT02017418 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 10 other Behavior and Behavior Mechanisms trials with a reported enrollment target (40% lower). The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Behavior and Behavior Mechanisms appearing as the primary indexed condition, and to 2 interventions - of which zeaxanthin is the first listed.

NCT02017418 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT02017418 about?

NCT02017418 is a clinical study titled "The Effects of a Zeaxanthin Intervention on Visuomotor Function". This study was designed to test whether two zeaxanthin formulations (supplements containing different nutritional compounds with zeaxanthin and omega fatty acids being the primary ingredients of interest) influenced visual motor function. Visual motor function refers to the processing speed of the v...

What is the current status of trial NCT02017418?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2012-02. Estimated completion is 2014-07.

What conditions does trial NCT02017418 study?

This clinical trial studies the following conditions: Behavior and Behavior Mechanisms.

What interventions are being tested in trial NCT02017418?

The interventions under investigation include: zeaxanthin (DIETARY_SUPPLEMENT), combinatory supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02017418?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02017418 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Behavior and Behavior Mechanisms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.